Is this you? Create Your Porfile
Avatar

Jörg Kallen

Novartis

Network

Latest external collaboration on country level. Dive into details by clicking on the dots.

Explore More

Hotspot

Dive into the research topics where Jörg Kallen is active.

Explore More

Publication

Featured researches published by Jörg Kallen.

Journal of Molecular Biology | 1999

Structural basis for LFA-1 inhibition upon lovastatin binding to the CD11a I-domain.

Jörg Kallen; Karl Welzenbach; Paul Ramage; Dieter Geyl; Richard W. Kriwacki; Glen B. Legge; Sylvain Cottens; Gabriele Weitz-Schmidt; Ulrich Hommel

Transplantation Proceedings | 1998

Chemical modification of rapamycin: the discovery of SDZ RAD

Richard Sedrani; Sylvain Cottens; Jörg Kallen; Walter Schuler

Journal of the American Chemical Society | 2003

Sanglifehrin-cyclophilin interaction: degradation work, synthetic macrocyclic analogues, X-ray crystal structure, and binding data.

Richard Sedrani; Jörg Kallen; Luisa M. Martin Cabrejas; Charles D. Papageorgiou; Francesco Senia; Stefan Rohrbach; Dieter Wagner; Binh Thai; Anne-Marie Jutzi Eme; Lukas Oberer; Grety Rihs; Gerhard Zenke; Jürgen Wagner

Archive | 1998

Lymphocyte function antigen-1 antagonists

Wilfried Bauer; Sylvain Cottens; Dieter Geyl; Gabriele Weitz-Schmidt; Jörg Kallen; Ulrich Hommel

Journal of Medicinal Chemistry | 1998

Rational design, synthesis, and X-ray structure of selective noncovalent thrombin inhibitors.

Jürgen Wagner; Jörg Kallen; Claus Ehrhardt; Jean-Pierre Evenou; Dieter Wagner

Journal of Molecular Biology | 1999

X-ray structure and conformational dynamics of the HIV-1 protease in complex with the inhibitor SDZ283-910: agreement of time-resolved spectroscopy and molecular dynamics simulations.

Sabine Ringhofer; Jörg Kallen; Raimund Dutzler; A Billich; A.J.W.G Visser; D Scholz; Othmar Steinhauser; Hellfried Schreiber; Manfred Auer; A.J Kungl

Angewandte Chemie | 1999

Makrolidanaloga des neuartigen Immunsuppressivums Sanglifehrin: eine neue Anwendung der Ringschluß‐Metathese

Luisa M. Martin Cabrejas; Stefan Rohrbach; Dieter Wagner; Jörg Kallen; Gerhard Zenke; Jürgen Wagner

Archive | 1975

Process for the production of 4-hydroxy-3,5-dibromobenzaldehyde

Henri Dietrich; Jörg Kallen; Gottfried Seifert

Archive | 2011

1H-quinazoline-2,4-diones processes for their production, pharmaceutical compositions, and treatment for epilepsy

Hans Allgeier; Yves Auberson; David Carcache; Philipp Floersheim; Christel Guibourdenche; Wolfgang Froestl; Jörg Kallen; Manuel Koller; Henri Mattes; Joachim Nozulak; David Orain; Johanne Renaud

Archive | 2009

1H-QUINAZ0LINE-2,4-DIONES

Hans Allgeier; Yves Auberson; David Carcache; Philipp Floersheim; Christel Guibourdenche; Wolfgang Froestl; Jörg Kallen; Manuel Koller; Henri Mattes; Joachim Nozulak; David Orain; Johanne Renaud

Explore More

Collaboration

Dive into the Jörg Kallen's collaboration.

Top Co-Authors
Avatar

Christel Guibourdenche

Novartis

View shared research outputs
Top Co-Authors
Avatar

David Carcache

Novartis

View shared research outputs
Top Co-Authors
Avatar

David Orain

Novartis

View shared research outputs
Top Co-Authors
Avatar

Hans Allgeier

Novartis

View shared research outputs
Top Co-Authors
Avatar

Henri Mattes

Novartis

View shared research outputs
Top Co-Authors
Avatar

Joachim Nozulak

Novartis

View shared research outputs
Top Co-Authors
Avatar

Johanne Renaud

Novartis

View shared research outputs
Top Co-Authors
Avatar

Manuel Koller

Novartis

View shared research outputs
Top Co-Authors
Avatar

Philipp Floersheim

Novartis

View shared research outputs
Top Co-Authors
Avatar

Wolfgang Froestl

Novartis

View shared research outputs
Explore More
Researchain Logo
Decentralizing Knowledge